ASX-Dividend-Report-Banner
Sponsored

Rritual Superfoods smashes full year US retail distribution targets within six months

June 09, 2021 05:31 PM AEST | By Team Kalkine Media
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Rritual Superfoods smashes full year US retail distribution targets within six months
Image source: Rritual Website

Summary

  • Plant-based elixirs developer Rritual Superfoods has surpassed its retail distribution targets for CY2021 within the first six months.
  • The Company has now revised its target to 6000 stores and 20,000 points of distribution by the end of 2021.
  • The superfood company has received retailer commitments to carry the Rritual brand. Rite Aid has suggested that additional 20% stores will now carry Rritual’s product.
  • Rritual shares soared following the announcement, ending the trading session 16.92% higher at CA$0.76 on 8 June.

In a significant announcement, functional superfood player Rritual Superfoods Inc (RSF:CSE) stated that it has surpassed its US retail distribution targets for the full year 2021 in less than half the time. The Company has already crossed 2400 retail locations and 10,000 points of distribution. As a result, Rritual’s leadership plans to revise the targets, aiming for 6000 stores and 20,000 points of distribution by the end of CY2021.

Following the favourable update, Rritual’s stock received a significant boost, with the shares surging 16.92% to close at CA$0.76 on 8 June.

Mr David Kerbel, CEO of Rritual, commented-

DO READ: Rritual Superfoods teams up with Ultimate Sales to make inroads into Canadian market

Rite Aid committed to carrying the Rritual brand

Rritual has revised the targets based on retailer commitments to carry the Rritual brand. For instance, Rite Aid has indicated that an additional 20% of its stores will carry Reishi Relax, Chaga Immune, and Lion's Mane Focus – which are Rritual’s three mushroom adaptogen formulations. Also, the Rite Aid locations offering Rritual’s Variety Pack would also double in number.

Rritual’s product line is being welcomed by consumers, with an initial sell-through with major retail partners generating new purchase orders (POs) and expansion of retail locations.

In the first week of July, the Company anticipates that its products would be available across 3000 retail locations with over 10,000 points of distribution. Additionally, as Rritual’s innovation pipeline provides new product offerings, there would be further growth in the distribution of its products.

Last week, the Company rolled out its superfood product line at Rite Aid’s e-commerce platform. The move will expand the distribution of Rritual’s plant-based products and boost consumer awareness across the US.

READ MORE: Rritual makes deeper inroads in the US with product launch on Rite Aid e-commerce platform

Plant-based food industry poised for significant growth

The plant-based food industry is anticipated to grow significantly in the coming decades providing further impetus for Rritual to expand its reach in the US and beyond. According to a research conducted by investment bank Credit Suisse, the plant-based food industry is projected for a monumental growth – it is set to grow 100 times by 2050.

The global food industry estimates that sales of plant-based food products will increase from US$14 billion to approximately US$1.4 trillion within next 30 years.

ALSO READ: Rritual Superfoods (RSF:CSE) in a sweet spot to excel in functional superfood market

What makes Rritual’s product more appealing is that they are all USDA-certified organic. They provide a caffeine-free product option and can be served in combination with other beverages or enjoyed by themselves. Furthermore, the proprietary Immune-Synergy Six Mushroom Blend is the only functional health formulation in the market that comprises a daily prebiotic blend to nourish a healthy gut microbiome.

MUST READ: A look at Rritual Superfoods’ lineup of natural elixirs


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.